P7C3-A20 – 1 mg

Brand:
Cayman
CAS:
1235481-90-9
Storage:
-20
UN-No:
Non-Hazardous - /

P7C3-A20 is a derivative of P7C3 (Item No. 16682) that has proneurogenic and neuroprotective activity.{41657} It increases proliferation in the subgranular zone (SGZ) of the adult mouse dentate gyrus in a dose-dependent manner when administered at doses ranging from 0.1 to 10 µM. It also protects U2OS cells from calcium-induced mitochondrial dissolution. In a rat model of traumatic brain injury, P7C3-A20 (10 mg/kg, i.p., twice daily for one week) decreases contusion volume, increases proliferation in the SGZ, and decreases the latency to reach the platform in the Morris water maze to sham surgery control levels.{41658} It also prevents or reverses dopaminergic cell death and motor deficits in a 6-OHDA rat model of Parkinson’s disease.{41659}  

 

Available on backorder

SKU: 24201 - 1 mg Category:

Description

A proneurogenic and neuroprotective compound; derivative of P7C3; increases proliferation the SGZ of the adult mouse dentate gyrus (0.1-10 µM); decreases contusion volume, increases proliferation in the SGZ, and improves learning in the Morris water maze (10 mg/kg, i.p., twice daily for one week); prevents or reverses dopaminergic cell death and motor deficits in a 6-OHDA rat model of Parkinson’s disease


Formal name: 3,6-dibromo-β-fluoro-N-(3-methoxyphenyl)-9H-carbazole-9-propanamine

Synonyms: 

Molecular weight: 506.2

CAS: 1235481-90-9

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease